Rapid Micro Biosystems (NASDAQ:RPID) Upgraded to Buy at Zacks Investment Research
Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Saturday, Zacks.com reports. The brokerage currently has a $7.00 price objective on the stock. Zacks Investment Research‘s target price points to a potential upside of 11.64% from the stock’s […]